What is the current Price Target for the Biohaven Pharmaceutical Holding Company Ltd. stock?

The average Biohaven Pharmaceutical Holding Company Ltd. target price is $51.00. This is 243.43% higher than the current stock price. The highest price target is 430.30%, the lowest is 29.23%. 16 Analysts have issued a price target Biohaven Pharmaceutical Holding Company Ltd. 2026 .

What's going on with the Biohaven Pharmaceutical Holding Company Ltd. stock today?

The performance of Biohaven Pharmaceutical Holding Company Ltd. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Biohaven Pharmaceutical Holding Company Ltd. Forecast, price target & analysts

Q: How high will the Biohaven Pharmaceutical Holding Company Ltd. stock rise?

No reliable answer can be given as to how high the Biohaven Pharmaceutical Holding Company Ltd. stock will rise. The performance of stocks, including the Biohaven Pharmaceutical Holding Company Ltd. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

Q: Why did the Biohaven Pharmaceutical Holding Company Ltd. stock fall?

The decline in Biohaven Pharmaceutical Holding Company Ltd. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

$14.16

4.65% today

NYSE, Sep 23, 09:48 pm CET

ISIN

VGG111961055

Symbol

BHVN

Reports

Quarter | Annual

Index

NYSE Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Biohaven Pharmaceutical Holding Company Ltd. Target price 2025 - Analyst rating & recommendation

Biohaven Pharmaceutical Holding Company Ltd. Classifications & Recommendation:

Buy

91%

Hold

Biohaven Pharmaceutical Holding Company Ltd. Price Target

Target Price	$51.00
Price	$14.85
Potential	243.43% register free of charge
Number of Estimates	16

	16 Analysts have issued a price target Biohaven Pharmaceutical Holding Company Ltd. 2026 . The average Biohaven Pharmaceutical Holding Company Ltd. target price is $51.00. This is 243.43% register free of charge higher than the current stock price. The highest price target is $78.75 430.30% register free of charge , the lowest is $19.19 29.23% register free of charge .
	A rating was issued by 22 analysts: 20 Analysts recommend Biohaven Pharmaceutical Holding Company Ltd. to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Biohaven Pharmaceutical Holding Company Ltd. stock has an average upside potential 2026 of 243.43% register free of charge . Most analysts recommend the Biohaven Pharmaceutical Holding Company Ltd. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-9.28	-7.82
	61.95%	15.73%
P/E		negative
EV/Sales		230.76

18 Analysts have issued a Biohaven Pharmaceutical Holding Company Ltd. forecast for earnings per share. The average Biohaven Pharmaceutical Holding Company Ltd. EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-9.28	61.95%
2025	$-7.82 15.73% Unlock
2026	$-5.98 23.53% Unlock
2027	$-4.15 30.60% Unlock
2028	$-2.32 44.10% Unlock
2029	$-0.29 87.50% Unlock
2030	$3.22 1,210.34% Unlock
2031	$7.58 135.40% Unlock
2032	$6.31 16.75% Unlock

Current	-1.98	58.28%
2025	-1.90 4.17% Unlock
2026	-2.48 30.53% Unlock
2027	-3.58 44.35% Unlock
2028	-6.40 78.77% Unlock
2029	-51.10 698.44% Unlock
2030	4.61 109.02% Unlock
2031	1.96 57.48% Unlock
2032	2.35 19.90% Unlock

Biohaven Pharmaceutical Holding Company Ltd....

Current Biohaven Pharmaceutical Holding Company Ltd. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Citigroup	Locked ➜ Locked	Locked	Sep 17 2025
UBS	Locked ➜ Locked	Locked	Sep 16 2025
Raymond James	Locked ➜ Locked	Locked	Sep 03 2025
BTIG	Locked ➜ Locked	Locked	Aug 19 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Aug 12 2025
B of A Securities	Locked ➜ Locked	Locked	Aug 12 2025
Morgan Stanley	Locked ➜ Locked	Locked	Aug 12 2025

Analyst Rating	Date
Locked Citigroup: Locked ➜ Locked	Sep 17 2025
Locked UBS: Locked ➜ Locked	Sep 16 2025
Locked Raymond James: Locked ➜ Locked	Sep 03 2025
Locked BTIG: Locked ➜ Locked	Aug 19 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Aug 12 2025
Locked B of A Securities: Locked ➜ Locked	Aug 12 2025
Locked Morgan Stanley: Locked ➜ Locked	Aug 12 2025

Discover more stocks with a high price target

BioNTech SE - ADR 41.55%

TUI 37.67%

Deutsche Telekom 36.48%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now